SANDOZ ,   Switzerland

Tablets, film-coated, 5 mg.

Solution for ingestion and inhalation 7.5 mg / ml.

Capsules of prolonged action 75 mg.

Tablets 200 mg.

Tablets 5 mg, 10 mg.

Tablets, film-coated 250 mg + 125 mg; 500 mg + 125 mg; 875 mg + 125 mg.

Powder for the preparation of a solution for intravenous administration of 500 mg + 100 mg. 1000 mg + 200 mg.

Powder for the preparation of a suspension for oral administration.

Tablets are dispersible 500 mg + 125 mg or 875 mg + 125 mg.

Tablets are dispersible, 125 mg + 31.25 mg, 250 mg + 62.50 mg.

Tablets, film-coated, 0.5 g and 1 g.

Tablets coated with a film coating, 50 mg / 12.5 mg and 100 mg / 25 mg.

Tablets 200 mg.

Cream for external use 5%.

Powder for external use 250 ME / g + 5000 MU / g.

Ointment for external use 250 IU / g + 5000 IU / g.

Film-coated tablets, 50 mg and 150 mg.

The solution for intravenous and subcutaneous administration was 16.8 μg / ml (1000 IU / 0.5 ml, 2000 IU / ml), 84 μg / ml (3000 IU / 0.3 ml, 4000 IU / 0.4 ml, 5000 IU (0.5 ml, 6000 IU / 0.6 ml, 8000 IU / 0.8 ml, 10,000 IU / ml), 336 μg / ml (20,000 IU / 0.5 ml, 30,000 IU / 0.75 ml, 40,000 IU / ml).

Tablets, film-coated, 2.5 mg.

Tablets, film-coated, 5 mg and 10 mg.

Tablets 2.5 mg.

Capsules 7.0 mg.

Capsules of 3.5 mg.

Tablets, film-coated 250 mg, 500 mg.

Gel for external use, 1%.

Capsules of prolonged action, 37.5 mg, 75 mg and 150 mg.

Lyophilizate for the preparation of a solution for infusions of 200 mg, 1000 mg.

Capsules.

Tablets, 5 mg, 10 mg and 20 mg.

Spray nasal 0,1 % For 10 ml or 15 ml preparation into a vial with a nebulizer from of low density polyethylene with screw cap from high density polyethylene, equipped with the first autopsy. Vial with instructions on application is enclosed in a pack of cardboard.

Kati nasal for children 0.05%. For 10 ml of bottles of dark glass with screwed aluminum cover, equipped with the first an autopsy complete with a screw-on cover with a polypropylene /polystyrene / rubber. Cover - pipette Packed in a sealed sachet of low density polyethylene. Bottle together with a pipette cap and manual for use in a pack of cardboard.

Nasal Spray 0.1%: in 10 ml plastic bottle (spray) of white low-density polyethylene with a screw cap of high density polyethylene, provided with a first opening control system. The bottle together with the instruction for use is enclosed in a pack of cardboard.

Nasal drops 0.05%: to 10 ml in dark glass vials with screw aluminum lid provided with the first opening control system complete with screw-krshzhoy pipette. One bottle together with the instruction for use is placed in a pack of cardboard.

Tablets, 10 mg.

Concentrate for solution for infusion, 10 mg / ml.

Pills, film coated 100 mg, 400 mg.

Solution for oral administration.

Solution for oral administration.

Tablets of prolonged film-coated effects, 1.5 mg

Concentrate for solution for infusion, 20 mg / ml.

Tablets effervescent 500 mg, 1000 mg.

Solution for intravenous and intramuscular injection 3 mg / ml.

Tablets 6.25 mg, 12.5 mg, 25 mg, 50 mg, 100 mg.

Concentrate for the preparation of a solution for infusions of 10 mg / ml (50 mg / 5 ml, 150 mg / 15 ml, 450 mg / 45 ml, 600 mg / 100 ml, 1000 mg / 100 ml).

Tablets coated with a film coating, 75 mg.

Gel for external use 2.5%.

Solution for intravenous and intramuscular injection 50 mg / ml.

Long-acting tablets 150 mg.

Suppositories rectal 100 mg.

Tablets, film-coated, 100 mg.

Capsules of prolonged action 200 mg.

Tablets 2 mg. 5 mg.

The film-coated tablets are 30 mg, 60 mg, 90 mg and 120 mg.

The coated tablets are 240 mg.

Solution for inhalation 10 mg / ml.

Eye drops 2 %.

Tablets, film-coated, 100 mg and 200 mg.

Capsules.

Suspension for oral administration, 5 mg / 5 ml.

Tablets for resorption, 10 mg.

Tablets 10 mg.

Tablets, film-coated, 10 mg.

Tablets, film-coated, 20 mg.

Tablets, film-coated, 500 mg, 850 mg and 1000 mg.

Capsules of prolonged action 0,4 mg.

Tablets, film-coated, 0.2 mg, 0.3 mg and 0.4 mg.

Tablets, 5 mg.

Capsules, 425 mg.

Tablets are enteric, film-coated 20 mg, 40 mg.

Tablets with modified release, film-coated 30 mg, 60 mg.

Liofilizate for the preparation of a solution for infusions, 50 mg and 100 mg.

Tablets, film-coated, 4 mg, 8 mg

Liofilizate for the preparation of a solution for infusions 40 mg.

Powder for the preparation of a suspension for ingestion 125 mg / 5 ml.

Tablets are dispersible, 500 mg, 750 mg and 1000 mg.

Tablets, film-coated, 200 mg.

Concentrate for the preparation of a solution for infusions of 30 mg / 5 ml, 100 mg / 16.7 ml, 150 mg / 25 ml, 210 mg / 35 ml or 300 mg / 50 ml (6 mg / ml).

Long-acting tablets, 600 mg.

10 tablets are placed in a blister of PP / aluminum foil.

For 3 or 5 blisters are placed in a cardboard box along with instructions for medical use.

Tablets, 0.625 mg + 2 mg and 1.25 mg + 4 mg.

Capsules.

Granules for solution preparation for ingestion for children

Capsules, 5 mg + 2.5 mg, 5 mg + 5 mg, 5 mg + 10 mg, 10 mg + 5 mg, 10 mg + 10 mg.

Powder for the preparation of suspension for intramuscular administration of prolonged action 1200000 ME, 2400000 ME.

Tablets, film-coated 5 mg or 10 mg.

Tablets coated with 5 mg, 10 mg, 20 mg, 30 mg, 40 mg.

For 10 tablets in a blister made of polyvinylchloride and aluminum foil.

For 1, 2, 3, 4 or 5 blisters in a pack of cardboard with instructions for use.

Tablets 80 mg, 160 mg

10 tablets per blister of polypropylene and aluminum

foil.

By 1, 2, 3, 5 or 10 blisters in cardboard pack with instruction on

application.

Capsules 0.5 mg, 1 mg, 5 mg.

10 capsules per blister of PVC / PE / PVDC / aluminum. By 5, 6, 9

or 10 blisters are placed in a bag (aluminum / aluminum) containing Desiccant with the inscription: "Not there is! ". For 1 package together with instruction on medical application is placed in cardboard pack.

Tablets coated with 10 mg, 20 mg, 30 mg, 40 mg.

For 10 tablets in a contour mesh box made of PVC / PVDC / aluminum foil.

By 3 or 10 contour mesh packages in a cardboard box with instructions for use.

Tablets of 10 mg, 20 mg, 30 mg and 40 mg mg.

Tablets 125 mg or 250 mg.

By 7, 10, 14, 21, 28, 42 tablets in a blister made of polyvinyl chloride and aluminum foil;

on 1, 2, 3, 4, 6, 14 blisters on 7 tablets in a cardboard pack; 1, 2, 3, 10 blisters of 10 tablets each in a cardboard box; 1, 2, 3, 7 blisters with 14 tablets each in a cardboard box; 1, 2 blisters with 21 tablets each in a cardboard box; 1, 2 blisters of 28 tablets each in a cardboard box; 1, 2 blisters for 42 tablets in a cardboard box;

For tablets 250 mg additionally:

8 tablets in a blister of polyvinyl chloride and aluminum foil; on 1, 7 blisters on 8 tablets in a cardboard pack;

In each pack put the instructions for use. For 14, 28, 56, 100 tablets in polyethylene bottles with screw caps. 1 bottle per cardboard pack together with instructions for use.

Tablets, film-coated, 500 mg.

Tablets 25 mg, 50 mg, 100 mg.

Tablets, film-coated 40 mg.

Tablets, film-coated 10 mg and 20 mg.

Transdermal therapeutic system, 25 mcg / hour, 50 mcg / h, 75 mcg / h, 100 mcg / h.

Transdermal therapeutic system, 25 mcg / hour, 50 mcg / h, 75 mcg / h, 100 mcg / h.

Tablets chewing 100 mg.

Syrup 50 mg / 5ml.

Solution for infusion, 5 mg / ml

Concentrate for the preparation of a solution for intravenous administration, 25 mg / ml.

Tablets, film-coated, 70 mg.

Capsules 25, 50 or 100 mg.

Solution for infusions 2 mg / ml.

Concentrate for solution for infusion, 0.5 mg / ml.

The film-coated tablets are 20 mg, 30 mg and 40 mg.

Lyophilizate for solution for infusion, 0.5 g and 1.0 g.

Solution for external use 1%. For 10 ml of solution in a vial of dark glass. 1 bottle with instructions for use in a cardboard pack.

Cream for external use 1%. For 15 or 30 grams of cream in an aluminum tube. 1 tuba together with instructions for use in a cardboard bundle.

Tablets of prolonged action, film-coated, 80 mg.

Syrup, 2 mg / ml.

Tablets, film-coated, 5 mg, 10 mg, 15 mg, 20 mg.